Insider trade

10% owner sold ~$11.1M of ROIV shares in the open market

Traded Nov 17, 2025 · Filed Nov 18, 2025

Why it stands out

A big owner of Roivant Sciences sold $11.1M of Roivant Sciences shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

10% owner$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$11,068,222

Shares × reported transaction price

Timing vs results

7 days after results of Nov 10, 2025, 81 days before results of Feb 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.7%	+2.3%	−0.6%
30 days	+6.2%	+2.5%	+3.7%
90 days	+32.0%	+3.5%	+28.6%
180 days	+39.1%	+11.9%	+27.2%

Past results only. Not a forecast.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.72, inclusive.

10mo ago

Not classified as an open-market trade.

10mo ago

Derivative exercise or conversion — not an open-market buy.

CEO sold

10mo ago

The boss of Roivant Sciences sold $4.99M of Roivant Sciences shares. Nobody planned it ahead of time.